raised their target price on shares of Kenvue from $24.00 to $25.00 and gave the stock an “overweight ... Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Receive News & Ratings for Kenvue ...
Wall Street's expectations appear to be that the company's slower-than-average growth is going to continue over the next few years. The problem in Starboard's view is that Kenvue's skin and beauty ...
Similarly, since KVUE's Zyrtec went off patent in 2007, consumers have seen a dramatic price reduction for generic versions of Cetirizine, the active ingredient in Zyrtec. For example, at Costco ...
At time of writing, the price reductions are already substantial. Although the exact dollar amount of the discounts depend heavily on the specific trim and packages selected, Tesla’s purchase ...
Kenvue is the business behind brands such as Aveeno, Listerine, Zyrtec, Tylenol ... since going public and currently trades at a forward price-to-earnings (P/E) multiple below that of the S ...